Overview
VANI market data
Price History
VANI price chart · 3M
- O
- 1.38
- H
- 1.52
- L
- 1.38
- C
- 1.49
- Vol
- 22,701.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $1.38
- Previous Close
- $1.38
- Day High
- $1.52
- Day Low
- $1.38
- 52 Week High
- $1.66
- 52 Week Low
- $0.95
- 7 Day Return
- +4.56%
- 30 Day Return
- +9.56%
- 90 Day Return
- +30.13%
- 1 Year Return
- +38.60%
- Daily Notional Volume
- $33.8K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.42 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.54 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -993.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.92 – $1.92 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $125.4M · P/B 5.70 · P/S 37.10.
Company News
8 captured
8-K filing — Vivani Medical, Inc. (VANI)SEC EDGAR ·
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live streamGlobenewswire Inc ·
Vivani Medical To Allow Novo Nordisk To Evaluate NPM-139, The Company’s Semaglutide Drug ImplantBenzinga ·